Hyloris Pharmaceuticals SA announces the US Food & Drug Administration has set 17 October 2023 as the date by which it expects to respond to the application regarding Maxigesic® IV.
Hyloris announces potential registration date for Maxigesic® IV in the US Read More »
La American Heart Association califica qué tan cerca se alinean varios patrones de alimentación populares con la guía para una alimentación saludable para el corazón.
Medtronic received FDA approval for the first leadless pacemaker in 2016, but faces a new competitor in Abbott, which got the nod for its own leadless device last year.
Medtronic ramps up competition for leadless pacemakers with newly approved devices Read More »
The tech giant is exiting the wearables sector as it eliminates 27,000 jobs this year. Amazon’s Halo devices will stop working on Aug. 1.
Amazon closes Halo health tracking unit as wave of tech layoffs continues Read More »
The move, if completed, would mean the end of the company as a health insurer.
Bright Health explores sale of California MA business Read More »
About half of nurses polled by AMN Healthcare said they were likely to encourage others to take up the profession in 2023, down from 64% in 2021.
The extended timeline to create a new regulatory system in England, Scotland and Wales is intended to prevent medical device shortages.
Great Britain proposes allowing CE marks until 2030 to minimize Brexit disruption Read More »
As it eliminates 27,000 jobs this year, the tech giant is exiting the wearables sector, and its Halo devices will stop working on Aug. 1.
Amazon closes Halo health tracking unit as wave of tech layoffs continues Read More »
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, shared data demonstrating the significant potential of using epigenetic reprogramming to rejuvenate skin before an international audience of regenerative aesthetics experts.
Crown Therapeutics, a division of Crown Laboratories, is proud to announce that PanOxyl® is expanding its award-winning portfolio with its new PM Balancing Repair Moisturizer and reformulating the existing AM Oil Control Moisturizer.
